It is also interesting that in esophageal carcinoma (ESCA), GBM, prostate adenocarcinoma (PRAD), SKCM and thymoma (THYM), expression of YIF1B was negatively correlated with most immune checkpoint molecules though, for some of them, not to a significant degree (Figure 9). Here, YIF1B is linked to prostate adenocarcinoma.